临床路径管理在儿科疾病中的应用效果评价

目的探讨临床路径管理在儿科疾病中应用效果。方法对比我院儿科对轮状病毒肠炎和支气管肺炎(非重症)实施临床路径管理前后,平均住院日、平均住院费用、药品比例、治愈率、患者满意度等方面的差异,并对实施过程中存在的问题进行分析。结果小儿轮状病毒肠炎实施临床路径管理完成率高,变异率小,平均住院费用、药品比例和抗菌药物使用率均低于实施前,患者满意度高于实施前,两组比较差异均有统计学意义(P<0.05)。小儿支气管肺炎(非重症)实施临床路径管理前后平均住院日、平均住院费用比较,差异无统计学意义(P>0.05),但实施路径管理后药品比例降低,患者满意度增加,实施前后比较,差异有统计学意义(P<0.05)。结论临床路径应用于儿科疾病管理后,诊疗过程更加规范,药品比例降低,显著提高医疗质量及患者满意度,值得各级医院广泛推广。

Application and evaluation of clinical pathway in management of pediatrics disease

Objective To study the effect of the implementation of clinical pathway in management of pediatrics disease.Methods To compare the average length of stay,the average proportion of hospital fees,medicines and cure rates,patient satisfaction in rotavirus enteritis and bronchial pneumonia(non-serious) before and after clinical path management,and analyzed the problems existing in the process of implementing.Results Rotavirus enteritis managed in clinical pathway got a high completion ratio with few variance.After the clinical pathway application,the medical cost,drugs ratio,and the use of antimicrobial drugs ratio were all decreased.Satisfaction of the patients was enhanced,even though there were no significant difference in hospital residence day.There were no statistical significant difference for the average length of stay,average hospital costs in that before and after implementation of clinical path children with bronchial pneumonia(non-severe)(P>0.05).After the implementation of the clinical pathway,the proportion of drugs was reduced,and patients satisfactory rate was also increased(P<0.05).Conclusions The application of clinical pathway in pediatrics can improve the health care quality,the treatment process became more standardized,drug ratio was decreased and patient satisfactory rate was significantly increased.Clinical pathway is worthy to be widely promoted.